GGrantIndex
Sort

40,608 grants matching prostate cancer

Vaccine and immunotherapy strategies for cancer and viruses causing cancer

$2,147,209
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

Prostate Cancer Susceptibility: The ICPCG Study

$2,146,285
William B Isaacs · Johns Hopkins University · U01 · FY2011 · CA

Toxic Substances in the Environment

$2,144,649
Martyn T Smith · University Of California Berkeley · P42 · FY2020 · ES

Image-Guided Adaptive Radiotherapy

$2,144,223
Jeffrey F Williamson · Virginia Commonwealth University · P01 · FY2009 · CA

Center for Pre-Clinical Cancer Research

$2,144,025
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM

Molecular Assays for epidemiology studies

$2,141,534
Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA

Genome-Wide Association Study of Endometrial Cancer

$2,141,499
Immaculata Devivo · Brigham And Women'S Hospital · R01 · FY2010 · CA

The Pacific Northwest Prostate Cancer SPORE

$2,140,568
Peter S Nelson · Fred Hutchinson Cancer Center · P50 · FY2025 · CA

BRAIN TUMOR SPORE GRANT

$2,140,227
Mitchel S. Berger · University Of California, San Francisco · P50 · FY2011 · CA

PLCO Trial Etiologic and Early Marker Study

$2,139,074
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

A CANCER TAXONOMY BASED ON GENE EXPRESSION PATTERNS

$2,139,071
Stanford University · U01 · FY2001 · CA

GENERAL CLINICAL RESEARCH CENTER

$2,137,837
University Of Iowa · M01 · FY2001 · RR

Multiethnic Cohort Study of Diet and Cancer

$2,136,335
University Of Hawaii At Manoa · R37 · FY2004 · CA

REVERSIBILITY AND THERAPEUTIC TARGETING OF TREATMENT- EMERGENT NEUROENDOCRINE PROSTATE CANCER

$2,136,000
Dana-Farber Cancer Institute, Inc. · · FY2025 · Defense Health Agency

PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: DANA-FARBER

$2,136,000
Dana-Farber Cancer Institute, Inc. · · FY2022 · Defense Health Agency

PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTE

$2,132,892
Lance L Yokochi · · N01 · FY2007 · CA

Risk Factors for Breast Cancer in Younger Nurses

$2,131,438
Walter C. Willett · Harvard School Of Public Health · R01 · FY2009 · CA

Mechanisms and Markers of Prostate Cancer Metastases

$2,127,334
Robert Vessella · University Of Washington · P01 · FY2011 · CA

SPORE in Prostate Cancer

$2,126,680
William J Catalona · Northwestern University At Chicago · P50 · FY2019 · CA

SPORE in Prostate Cancer

$2,126,579
Yu Chen · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

Image-Guided Adaptive Radiotherapy

$2,125,771
Jeffrey F Williamson · Virginia Commonwealth University · P01 · FY2008 · CA

The Role of PTEN and the PI3K Pathway in Prostate Cancer

$2,125,652
Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2007 · CA

Weill Cornell Medicine (WCM) SPORE in Prostate Cancer

$2,122,802
Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · CA

Weill Cornell Medicine (WCM) SPORE in Prostate Cancer

$2,122,802
Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · CA

Molecular Epidemiology of Nutrition and Cancer in the Multiethnic Cohort Study

$2,120,588
Laurence N. Kolonel · University Of Hawaii At Manoa · P01 · FY2009 · CA